Concurrent paclitaxel/radiotherapy in locally advanced stage IIIA/B non-small cell lung cancer: Results of a clinical phase I study

被引:0
|
作者
Vogt, HG
Kolotas, C
Martin, T
Schneider, LV
GoesSchmieder, R
Diergarten, K
Zamboglou, N
机构
[1] UNIV FRANKFURT,STADT KLINIKEN OFFENBACH,DEPT RADIAT MED,D-63069 OFFENBACH,GERMANY
[2] BRISTOL MYERS SQUIBB CO,MUNICH,GERMANY
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S19 / S24
页数:6
相关论文
共 50 条
  • [31] Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer
    Choy, H
    Akerley, W
    DeVore, RF
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 36 - 43
  • [32] Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: Results from 2 phase I studies
    Surmont, V.
    Smit, E. F.
    de Jonge, M.
    Aerts, J. G.
    Nackaerts, K.
    Vernhout, R.
    Gras, J.
    Van Wijk, A.
    Phernambucq, E. C. J.
    van Meerbeeck, J. P.
    Senan, S.
    Kraaij, C. J.
    Chouaki, N.
    Praag, J.
    van Klaveren, R. J.
    LUNG CANCER, 2010, 69 (03) : 302 - 306
  • [33] Concurrent chemoradiation using paclitaxel and carboplatin in locally advanced non-small cell lung cancer
    Langer, CJ
    SEMINARS IN RADIATION ONCOLOGY, 1999, 9 (02) : 108 - 116
  • [34] Concurrent chemoradiation therapy with weekly paclitaxel for locally advanced non-small cell lung cancer
    Kim, S
    Kim, S
    Shim, B
    Kim, C
    Song, S
    Ahn, M
    Jeong, Y
    Yoo, J
    Kim, H
    LUNG CANCER, 2005, 49 : S380 - S381
  • [35] Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer
    Oka, M
    Fukuda, M
    Fukuda, M
    Kinoshita, A
    Kuba, M
    Ichiki, M
    Rikimaru, T
    Soda, H
    Takatani, H
    Narasaki, F
    Nagashima, S
    Nakamura, YI
    Hayashi, N
    Kohno, S
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (11) : 1359 - 1365
  • [36] Accelerated hypofractionated radiotherapy with concurrent full dose chemotherapy for locally advanced non-small cell lung cancer: A phase I/II study
    Glinski, Krzysztof
    Socha, Joanna
    Wasilewska-Tesluk, Ewa
    Komosinska, Katarzyna
    Kepka, Lucyna
    RADIOTHERAPY AND ONCOLOGY, 2020, 148 : 174 - 180
  • [37] Therapy of non-small cell lung cancer in the locally advanced stage (inoperable IIIA/IIIB)
    Baumann, Michael
    Dienemann, Hendrik C.
    Fietkau, Rainer
    Ruebe, Christian
    Thomas, Michael
    ONKOLOGIE, 2006, 29 : 11 - 14
  • [38] Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer
    Tsuchiya-Kawano, Yuko
    Sasaki, Tomonari
    Yamaguchi, Hiroyuki
    Hirano, Katsuya
    Horiike, Atsushi
    Satouchi, Miyako
    Hosokawa, Shinobu
    Morinaga, Ryotaro
    Komiya, Kazutoshi
    Inoue, Koji
    Fujita, Yuka
    Toyozawa, Ryo
    Kimura, Tomoki
    Takahashi, Kosuke
    Nishikawa, Kazuo
    Kishimoto, Junji
    Nakanishi, Yoichi
    Okamoto, Isamu
    ONCOLOGIST, 2020, 25 (06): : 475 - +
  • [39] Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer
    Omori, Shota
    Harada, Hideyuki
    Mori, Keita
    Hisamatsu, Yasushi
    Tsuboguchi, Yuko
    Yoshioka, Hiroshige
    Morinaga, Ryotaro
    Daga, Haruko
    Kurata, Takayasu
    Takahashi, Toshiaki
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 106 - 114
  • [40] Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer
    Shota Omori
    Hideyuki Harada
    Keita Mori
    Yasushi Hisamatsu
    Yuko Tsuboguchi
    Hiroshige Yoshioka
    Ryotaro Morinaga
    Haruko Daga
    Takayasu Kurata
    Toshiaki Takahashi
    Investigational New Drugs, 2022, 40 : 106 - 114